Company Filing History:
Years Active: 1992-2001
Title: Innovator Spotlight: Stephen P. Squinto
Introduction: Stephen P. Squinto, an accomplished inventor based in Irvington, NY, has made significant contributions to the field of neurobiology. With a total of eight patents to his name, his work primarily revolves around the ciliary neurotrophic factor (CNTF) and its receptor, demonstrating his deep commitment to advancing medical science.
Latest Patents: Among his latest patents is a groundbreaking method for screening cells that express the CNTF receptor. This invention includes key components such as nucleic acid and amino acid sequences related to the CNTF receptor. The patent outlines several applications including assay systems for detecting CNTF activity, experimental models for studying CNTF's physiological role, diagnostic techniques for identifying neurologic conditions related to CNTF, and therapeutic techniques for treating such conditions. Another notable patent involves the creation of CNTF receptor antibodies, also aimed at facilitating diagnostic techniques for CNTF-related neurologic conditions.
Career Highlights: Stephen P. Squinto is a key researcher at Regeneron Pharmaceuticals, Inc., a leading biotechnology company known for its innovative approaches to drug discovery and development. His contributions have not only enriched his organization but have also played a role in improving therapeutic strategies in neurology.
Collaborations: Throughout his career, Squinto has collaborated with various distinguished individuals in the research community, including his coworkers Mark E. Furth and George D. Yancopoulos. These collaborations have fostered an environment of innovation, pushing boundaries in neurobiological research.
Conclusion: Stephen P. Squinto's work exemplifies the spirit of innovation in the scientific community. With numerous patents that hold potential for significant medical advancements, his contributions continue to influence the landscape of neurobiology and therapeutic solutions for neurologic conditions. His journey underscores the importance of collaboration in driving forward meaningful inventions that can change lives.